Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer
Jia-Ning Zhang,1,2,* Lin-Wei Li,1,2,* Man-Qing Cao,1,2,* Xin Liu,1,2 Zi-Lu Yi,1,2 Sha-Sha Liu,1,2 Hong Liu1,2 1The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Labora...
Saved in:
Main Authors: | Zhang JN, Li LW, Cao MQ, Liu X, Yi ZL, Liu SS, Liu H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/functional-analysis-and-experimental-validation-of-the-prognostic-and--peer-reviewed-fulltext-article-BCTT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Underlying and contributing causes of mortality from CDC WONDER—Insights for researchers
by: Abdul Mannan Khan Minhas, et al.
Published: (2025-02-01) -
CDC20 and CCNB1 Overexpression as Prognostic Markers in Bladder Cancer
by: Hatice Sevim Nalkiran, et al.
Published: (2024-12-01) -
Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCC
by: Chenxuan Li, et al.
Published: (2025-03-01) -
Mutation in CDC42 Gene Set as a Response Biomarker for Immune Checkpoint Inhibitor Therapy
by: Kun Wang, et al.
Published: (2025-01-01) -
Biallelic mutations in CDC20 cause female infertility due to oocyte maturation abnormality
by: Guangzhong Jiao, et al.
Published: (2025-12-01)